
Webinar
Understand and Mitigate Interface-Induced Risks in Biopharmaceutical Development with QSense QCM-D
Join this webinar to learn how QSense QCM-D can be used to investigate interface-related risks in biopharmaceutical development, from early developability through formulation and fill–finish.
Surface-induced processes such as adsorption, unfolding and aggregation at solid–liquid interfaces are increasingly recognized as potential contributors to subvisible particles (SVPs), long-term interfacial changes and material compatibility issues.
In this session, Fredrik Pettersson, Senior Application Scientist at Biolin Scientific, will show how nanoscale adsorption measurements using QSense QCM-D can help establish mechanistic links to macroscopic outcomes such as SVP formation, aggregation, and interfacial instability over time.
Webinar details
-
Date
March 10, 09:00 CET
-
Length
1 hour
-
Presentation by
Fredrik Pettersson
-
Technologies
QCM-D
In this webinar:
The webinar presents recent case studies from publications where QSense QCM-D was applied to development-relevant questions across molecule selection, formulation, container/closure compatibility, fill–finish equipment materials, and long-term interfacial stability. Together, the examples illustrate how QSense can complement traditional stress testing and bulk assays, and support more informed discussion around molecule, excipient and material choices.
The webinar may be of particular interest to professionals involved in biopharmaceutical development who are interested in incorporating interface-focused, mechanistic insights into their work.
Agenda
-
Overview: Interface-induced instabilities and whysurfaces matter in biopharma development
-
QSense QCM-D as a mechanistic tool for antibody–surface interaction and stability assessment
-
Case examples from recent publications
-
Q&A
Presentation by Fredrik Pettersson
Register